A comparative study of preclinical and clinical molecular imaging response to EGFR inhibition using osimertinib in glioblastoma
Related Posts
Cai X, White Q, Johnson WC, Hansen SL, Dardari ZA, Blaha M, Michos ED, Lima JA, deFilippi CR, Budoff MJ, Watson KE, McClelland RL, Yang[...]
Jordan E, Ni H, Parker P, Kinnamon DD, Owens A, Lowes B, Shenoy C, Martin CM, Judge DP, Fishbein DP, Stoller D, Minami E, Kransdorf[...]
Ebrahimian S, Coaston T, Vadlakonda A, Hadaya J, Sakowitz S, Nsair A, Zinoviev R, Ziaeian B, Yang EH, Fonarow GC, Aksoy O, Benharash P. Outcomes[...]